Clinical trial NCT03588572 - References

Ischemic Stroke — The Effect of Venlafaxine on Language Function in Patients With Subcortical Aphasia: A fMRI Study

Citation(s)

•   Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd
  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 Jan;24(1):35-41.
•   Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N
  The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2009 Apr;259(3):172-85. doi: 10.1007/s00406-008-0849-0. Epub 2009 Jan 22.
•   Béïque J, de Montigny C, Blier P, Debonnel G
  Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat. Neuropharmacology. 2000 Jul 24;39(10):1813-22.
•   Berrocoso E, Mico JA
  Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice. Int J Neuropsychopharmacol. 2009 Feb;12(1):61-71. doi: 10.1017/S1461145708008766. Epub 2008 Apr 14.
•   Berthier ML, Pulvermüller F, Dávila G, Casares NG, Gutiérrez A
  Drug therapy of post-stroke aphasia: a review of current evidence. Neuropsychol Rev. 2011 Sep;21(3):302-17. doi: 10.1007/s11065-011-9177-7. Epub 2011 Aug 16. Review.
•   Berthier ML
  Poststroke aphasia : epidemiology, pathophysiology and treatment. Drugs Aging. 2005;22(2):163-82. Review.
•   Beversdorf DQ, Sharma UK, Phillips NN, Notestine MA, Slivka AP, Friedman NM, Schneider SL, Nagaraja HN, Hillier A
  Effect of propranolol on naming in chronic Broca's aphasia with anomia. Neurocase. 2007 Aug;13(4):256-9.
•   Damasio H, Grabowski TJ, Tranel D, Hichwa RD, Damasio AR
  A neural basis for lexical retrieval. Nature. 1996 Apr 11;380(6574):499-505. Erratum in: Nature 1996 Jun 27;381(6595):810.
•   Debonnel G, Saint-André E, Hébert C, de Montigny C, Lavoie N, Blier P
  Differential physiological effects of a low dose and high doses of venlafaxine in major depression. Int J Neuropsychopharmacol. 2007 Feb;10(1):51-61. Epub 2006 May 11.
•   Dickey L, Kagan A, Lindsay MP, Fang J, Rowland A, Black S
  Incidence and profile of inpatient stroke-induced aphasia in Ontario, Canada. Arch Phys Med Rehabil. 2010 Feb;91(2):196-202. doi: 10.1016/j.apmr.2009.09.020.
•   Engelter ST, Gostynski M, Papa S, Frei M, Born C, Ajdacic-Gross V, Gutzwiller F, Lyrer PA
  Epidemiology of aphasia attributable to first ischemic stroke: incidence, severity, fluency, etiology, and thrombolysis. Stroke. 2006 Jun;37(6):1379-84. Epub 2006 May 11.
•   Feeney DM, Sutton RL
  Pharmacotherapy for recovery of function after brain injury. Crit Rev Neurobiol. 1987;3(2):135-97. Review.
•   Fernandez B, Cardebat D, Demonet JF, Joseph PA, Mazaux JM, Barat M, Allard M
  Functional MRI follow-up study of language processes in healthy subjects and during recovery in a case of aphasia. Stroke. 2004 Sep;35(9):2171-6. Epub 2004 Aug 5.
•   Folstein MF, Folstein SE, McHugh PR
  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98.
•   Hamilton M
  Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967 Dec;6(4):278-96.
•   HAMILTON M
  The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-5.
•   Herrera-Guzmán I, Herrera-Abarca JE, Gudayol-Ferré E, Herrera-Guzmán D, Gómez-Carbajal L, Peña-Olvira M, Villuendas-González E, Joan GO
  Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder. Psychiatry Res. 2010 May 30;177(3):323-9. doi: 10.1016/j.psychres.2010.03.006. Epub 2010 Apr 10.
•   Kertesz A
  Western Aphasia Battery test manual. New York:NY: Grune & Stratton,1982.
•   Kim H, Na DL
  Normative data on the Korean version of the Western Aphasia Battery. J Clin Exp Neuropsychol. 2004 Nov;26(8):1011-20.
•   Kim YH, You SH, Ko MH, Park JW, Lee KH, Jang SH, Yoo WK, Hallett M
  Repetitive transcranial magnetic stimulation-induced corticomotor excitability and associated motor skill acquisition in chronic stroke. Stroke. 2006 Jun;37(6):1471-6. Epub 2006 May 4. Erratum in: Stroke. 2006 Nov;37(11):2861.
•   Li CY, Song XZ, Han LX, Xie Q, Wang J, Li YK, Liu FD, Liu Y
  The effects of venlafaxine on cortical motor area activity in healthy subjects: a pilot study. J Clin Psychopharmacol. 2014 Feb;34(1):93-8. doi: 10.1097/JCP.0000000000000056.
•   Luria AR, Simernitskaya EG, Tubylevich B
  The structure of psychological processes in relation to cerebral organization. Neuropsychologia. 1970 Jan;8(1):13-9.
•   Nemeroff CB, Entsuah R, Benattia I, Demitrack M, Sloan DM, Thase ME
  Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs. Biol Psychiatry. 2008 Feb 15;63(4):424-34. Epub 2007 Sep 24.
•   Pedersen PM, Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS
  Aphasia in acute stroke: incidence, determinants, and recovery. Ann Neurol. 1995 Oct;38(4):659-66.
•   Rickels K, Mangano R, Khan A
  A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder. J Clin Psychopharmacol. 2004 Oct;24(5):488-96.
•   Rudolph RL, Entsuah R, Chitra R
  A meta-analysis of the effects of venlafaxine on anxiety associated with depression. J Clin Psychopharmacol. 1998 Apr;18(2):136-44.
•   Schmitt AB, Bauer M, Volz HP, Moeller HJ, Jiang Q, Ninan PT, Loeschmann PA
  Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity. Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):329-39. doi: 10.1007/s00406-009-0003-7. Epub 2009 Mar 3.
•   Schweizer E, Thielen RJ, Frazer A
  Venlafaxine:a novel antidepressant compound. Expert Opin Investig Drugs. 1997 Jan;6(1):65-78.
•   Thase ME, Entsuah AR, Rudolph RL
  Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry. 2001 Mar;178:234-41.
•   Thase ME, Entsuah R, Cantillon M, Kornstein SG
  Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions. J Womens Health (Larchmt). 2005 Sep;14(7):609-16.
•   Walker-Batson D, Curtis S, Natarajan R, Ford J, Dronkers N, Salmeron E, Lai J, Unwin DH
  A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke. 2001 Sep;32(9):2093-8.
•   Xie Q, Liu Y, Li CY, Song XZ, Wang J, Han LX, Bai HM
  The modulation of venlafaxine on cortical activation of language area in healthy subjects with fMRI study. Psychopharmacology (Berl). 2012 Oct;223(4):417-25. Epub 2012 May 4.

A Randomized, Single Blind, Controlled, Longitudinal Study of the Effects of Venlafaxine Hydrochloride Capsules on the Language Function of Stroke Patients With Subcortical Aphasia Using fMRI

Details for clinical trial NCT03588572